TD Waterhouse Canada Inc. Increases Stock Position in CVS Health Corporation $CVS

TD Waterhouse Canada Inc. grew its stake in CVS Health Corporation (NYSE:CVS) by 43.0% during the second quarter, according to its most recent 13F filing with the SEC. The firm owned 452,488 shares of the pharmacy operator’s stock after acquiring an additional 136,033 shares during the period. TD Waterhouse Canada Inc.’s holdings in CVS Health were worth $47,448,000 as of its most recent filing with the SEC.

A number of other hedge funds have also recently made changes to their positions in CVS. BlackRock Inc. purchased a new stake in CVS Health in the second quarter valued at approximately $12,747,462,000. Norges Bank purchased a new position in shares of CVS Health during the fourth quarter worth $1,666,265,000. Bank of America Corp DE grew its stake in shares of CVS Health by 148.0% in the second quarter. Bank of America Corp DE now owns 23,188,670 shares of the pharmacy operator’s stock valued at $2,398,868,000 after buying an additional 13,836,701 shares in the last quarter. Wellington Management Group LLP grew its stake in shares of CVS Health by 193.2% in the fourth quarter. Wellington Management Group LLP now owns 18,564,392 shares of the pharmacy operator’s stock valued at $1,473,270,000 after buying an additional 12,233,675 shares in the last quarter. Finally, Pzena Investment Management LLC purchased a new stake in shares of CVS Health in the 2nd quarter valued at $1,217,558,000. Hedge funds and other institutional investors own 80.66% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of brokerages recently commented on CVS. Cantor Fitzgerald raised their target price on CVS Health from $100.00 to $110.00 and gave the company an “overweight” rating in a report on Tuesday, July 7th. Weiss Ratings upgraded shares of CVS Health from a “hold (c+)” rating to a “buy (b-)” rating in a research note on Wednesday, August 5th. Royal Bank Of Canada raised their price objective on shares of CVS Health from $107.00 to $113.00 and gave the company an “outperform” rating in a research note on Thursday, July 9th. Barclays lifted their price objective on shares of CVS Health from $106.00 to $108.00 and gave the company an “overweight” rating in a report on Thursday, August 6th. Finally, Deutsche Bank Aktiengesellschaft raised their price target on shares of CVS Health from $88.00 to $92.00 and gave the company a “buy” rating in a research report on Thursday, May 7th. Twenty-two investment analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $106.83.

CVS Health Stock Performance

Shares of CVS opened at $97.14 on Friday. CVS Health Corporation has a 1 year low of $69.51 and a 1 year high of $110.68. The stock has a market capitalization of $124.24 billion, a PE ratio of 25.70, a PEG ratio of 0.95 and a beta of 0.59. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.66 and a current ratio of 0.87. The stock has a 50-day simple moving average of $100.94 and a 200-day simple moving average of $90.09.

CVS Health (NYSE:CVS) last released its earnings results on Wednesday, August 5th. The pharmacy operator reported $2.58 earnings per share for the quarter, topping analysts’ consensus estimates of $1.87 by $0.71. The firm had revenue of $106.10 billion for the quarter, compared to analyst estimates of $100.03 billion. CVS Health had a net margin of 1.18% and a return on equity of 13.12%. The business’s quarterly revenue was up 7.3% compared to the same quarter last year. During the same period in the prior year, the firm earned $1.81 earnings per share. CVS Health has set its FY 2026 guidance at 7.900-8.100 EPS. On average, analysts predict that CVS Health Corporation will post 8.02 earnings per share for the current fiscal year.

CVS Health Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Monday, August 3rd. Stockholders of record on Thursday, July 23rd were given a dividend of $0.665 per share. This represents a $2.66 annualized dividend and a dividend yield of 2.7%. The ex-dividend date of this dividend was Thursday, July 23rd. CVS Health’s payout ratio is 70.37%.

CVS Health Company Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.